Related Experiment Video
Updated: Mar 9, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK
Andrew M Kidger1, Linda K Rushworth1, Julia Stellzig1
1Stress Response Laboratory, Division of Cancer Research, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, United Kingdom.
Abstract:
Deregulated extracellular signal-regulated kinase (ERK) signaling drives cancer growth. Normally, ERK activity is self-limiting by the rapid inactivation of upstream kinases and delayed induction of dual-specificity MAP kinase phosphatases (MKPs/DUSPs). However, interactions between these feedback mechanisms are unclear. Here we show that, although the MKP DUSP5 both inactivates and anchors ERK in the nucleus, it paradoxically increases and prolongs cytoplasmic ERK activity. The latter effect is caused, at least in part, by the relief of ERK-mediated RAF inhibition. The importance of this spatiotemporal interaction between these distinct feedback mechanisms is illustrated by the fact that expression of oncogenic BRAFV600E, a feedback-insensitive mutant RAF kinase, reprograms DUSP5 into a cell-wide ERK inhibitor that facilitates cell proliferation and transformation. In contrast, DUSP5 deletion causes BRAFV600E-induced ERK hyperactivation and cellular senescence. Thus, feedback interactions within the ERK pathway can regulate cell proliferation and transformation, and suggest oncogene-specific roles for DUSP5 in controlling ERK signaling and cell fate.
Insights
Dual-specificity MAP kinase phosphatases (MKPs/DUSPs), like DUSP5, normally limit extracellular signal-regulated kinase (ERK) signaling. This study reveals DUSP5 paradoxically enhances cytoplasmic ERK activity, impacting cancer cell proliferation and transformation.
Area of Science:
- Cellular signaling pathways
- Cancer biology
- Molecular mechanisms of cancer
Background:
- Extracellular signal-regulated kinase (ERK) signaling is crucial for cell growth and is tightly regulated by feedback mechanisms.
- Dual-specificity MAP kinase phosphatases (MKPs/DUSPs) are key negative regulators of ERK signaling, but their precise interactions with other feedback loops are not fully understood.
Purpose of the Study:
- To elucidate the complex interactions between DUSP5 and other feedback mechanisms within the ERK signaling pathway.
- To investigate the role of DUSP5 in regulating ERK activity in the context of oncogenic mutations, specifically BRAFV600E.
Main Methods:
- Investigated the subcellular localization and enzymatic activity of DUSP5 in relation to ERK.
- Utilized genetic manipulation (DUSP5 deletion) and expression of oncogenic BRAFV600E to study feedback loop dynamics.
- Assessed the impact of these manipulations on ERK signaling, cell proliferation, and cell fate.
Main Results:
- DUSP5 anchors and inactivates ERK in the nucleus but paradoxically increases and prolongs cytoplasmic ERK activity by relieving RAF inhibition.
- Expression of oncogenic BRAFV600E reprograms DUSP5 into a cell-wide ERK inhibitor, promoting proliferation and transformation.
- DUSP5 deletion leads to BRAFV600E-induced ERK hyperactivation and cellular senescence.
Conclusions:
- Feedback interactions within the ERK pathway are critical for controlling cell proliferation and transformation.
- DUSP5 plays an oncogene-specific role in modulating ERK signaling and cell fate, highlighting its complex regulatory function.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases

